Advantage Alpha Capital Partners LP Tg Therapeutics, Inc. Transaction History
Advantage Alpha Capital Partners LP
- $361 Million
- Q1 2025
A detailed history of Advantage Alpha Capital Partners LP transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 20,588 shares of TGTX stock, worth $740,962. This represents 0.22% of its overall portfolio holdings.
Number of Shares
20,588
Previous 13,447
53.1%
Holding current value
$740,962
Previous $404,000
100.74%
% of portfolio
0.22%
Previous 0.1%
Shares
4 transactions
Others Institutions Holding TGTX
# of Institutions
411Shares Held
87.9MCall Options Held
2.34MPut Options Held
2.01M-
Vanguard Group Inc Valley Forge, PA15.6MShares$562 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$410 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$268 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.28MShares$118 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.85MShares$102 Million9.29% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.23B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...